Estrigenix Therapeutics
Developing selective estrogen receptor-beta therapeutics for women's health and neurodegenerative diseases
$2MSeed
Role not disclosedLoading investors…
Activity from announced rounds
Developing selective estrogen receptor-beta therapeutics for women's health and neurodegenerative diseases